- This event has passed.
Faculty Candidate Talk: Kevin Drew, PhD
December 10, 2019 @ 12:00 pm - 1:30 pm
Speaker: Kevin Drew, PhD
Postdoctoral Fellow
University of Texas Austin
Talk Title: “Mapping the Molecular Machines of the Cell: Human Ciliopathy Complexes and Beyond”
About the Speaker: Kevin Drew is an NIH K99/R00 Pathway to Independence Fellow at the University of Texas at Austin in the labs of Drs. Edward Marcotte and John Wallingford. Drew uses cutting-edge computational and proteomics techniques to study large macromolecular assemblies providing insight into fundamental biological processes as well as human disease. Before UT-Austin, Drew received his PhD from New York University in the lab of Dr. Richard Bonneau. Additionally, he holds a master’s degree in computer science from the University of Chicago and a bachelor’s degree in computer science from the University of Iowa.
About the Cluster Hire:
UW’s Cluster Hiring Initiative was launched in 1998 as an innovative partnership between the university, state and the Wisconsin Alumni Research Foundation (WARF). In its first phase, the initiative authorized nearly 50 “clusters” and nearly 150 new faculty through several rounds of hiring. In 2017, phase two of the Cluster Hiring Initiative was authorized with a goal of supporting at least 12 clusters.
A proposal by several Waisman Center investigators for a Functional Genetics/Genomics of Neurodevelopmental and Neurodegenerative Diseases cluster at the Waisman Center was selected by the UW-Madison Cluster Hire Initiative.
New faculty hires who are part of the Functional Genetics/Genomics of Neurodevelopmental and Neurodegenerative Diseases cluster at the Waisman Center will help develop a pipeline of discovery that begins with patients in the clinics and ends with new approaches for treatments or therapies. This cycle of translational research would start with identifying patient-specific genetic variants, and then continue through experimental studies to confirm whether these variants truly cause disease. Ultimately, new panels for diagnosis and new approaches for treatment may be discovered.
